Based on the analysis of Ensign's profitability, liquidity, and operating efficiency, The Ensign Group may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. At this time, Ensign's Total Stockholder Equity is most likely to increase significantly in the upcoming years. The Ensign's current Net Debt is estimated to increase to about 1.6 B, while Common Stock Total Equity is projected to decrease to roughly 39.2 K. Key indicators impacting Ensign's financial strength include:
Investors should never underestimate Ensign's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Ensign's cash flow, debt, and profitability to make informed and accurate decisions about investing in The Ensign Group.
Net Income
312.87 Million
Ensign
Select Account or Indicator
Market Cap
Enterprise Value
Price To Sales Ratio
Dividend Yield
Ptb Ratio
Days Sales Outstanding
Book Value Per Share
Free Cash Flow Yield
Operating Cash Flow Per Share
Stock Based Compensation To Revenue
Capex To Depreciation
Pb Ratio
Ev To Sales
Free Cash Flow Per Share
Roic
Inventory Turnover
Net Income Per Share
Days Of Inventory On Hand
Payables Turnover
Sales General And Administrative To Revenue
Average Inventory
Capex To Revenue
Cash Per Share
Pocfratio
Interest Coverage
Payout Ratio
Capex To Operating Cash Flow
Pfcf Ratio
Days Payables Outstanding
Income Quality
Roe
Ev To Operating Cash Flow
Pe Ratio
Return On Tangible Assets
Ev To Free Cash Flow
Earnings Yield
Intangibles To Total Assets
Net Debt To E B I T D A
Current Ratio
Tangible Book Value Per Share
Receivables Turnover
Graham Number
Shareholders Equity Per Share
Debt To Equity
Capex Per Share
Graham Net Net
Revenue Per Share
Interest Debt Per Share
Debt To Assets
Enterprise Value Over E B I T D A
Short Term Coverage Ratios
Price Earnings Ratio
Operating Cycle
Price Book Value Ratio
Price Earnings To Growth Ratio
Days Of Payables Outstanding
Dividend Payout Ratio
Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio
Pretax Profit Margin
Ebt Per Ebit
Operating Profit Margin
Effective Tax Rate
Company Equity Multiplier
Long Term Debt To Capitalization
Total Debt To Capitalization
Return On Capital Employed
Debt Equity Ratio
Ebit Per Revenue
Quick Ratio
Dividend Paid And Capex Coverage Ratio
Net Income Per E B T
Cash Ratio
Cash Conversion Cycle
Operating Cash Flow Sales Ratio
Days Of Inventory Outstanding
Days Of Sales Outstanding
Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios
Price To Book Ratio
Fixed Asset Turnover
Capital Expenditure Coverage Ratio
Price Cash Flow Ratio
Enterprise Value Multiple
Debt Ratio
Cash Flow To Debt Ratio
Price Sales Ratio
Return On Assets
Asset Turnover
Net Profit Margin
Gross Profit Margin
Price Fair Value
Return On Equity
Sale Purchase Of Stock
Change In Cash
Stock Based Compensation
Free Cash Flow
Change In Working Capital
Begin Period Cash Flow
Other Cashflows From Financing Activities
Depreciation
Other Non Cash Items
Dividends Paid
Capital Expenditures
Total Cash From Operating Activities
Net Income
Total Cash From Financing Activities
End Period Cash Flow
Change To Liabilities
Change To Inventory
Change To Account Receivables
Other Cashflows From Investing Activities
Investments
Change Receivables
Net Borrowings
Total Cashflows From Investing Activities
Cash And Cash Equivalents Changes
Cash Flows Other Operating
Change To Netincome
Change To Operating Activities
Total Assets
Short Long Term Debt Total
Total Stockholder Equity
Net Debt
Cash
Other Assets
Cash And Short Term Investments
Common Stock Shares Outstanding
Liabilities And Stockholders Equity
Non Current Liabilities Total
Other Stockholder Equity
Total Liab
Total Current Assets
Other Current Liab
Total Current Liabilities
Property Plant And Equipment Net
Retained Earnings
Accounts Payable
Non Current Assets Total
Non Currrent Assets Other
Net Receivables
Common Stock Total Equity
Other Current Assets
Property Plant And Equipment Gross
Accumulated Other Comprehensive Income
Short Term Debt
Intangible Assets
Common Stock
Other Liab
Long Term Debt
Good Will
Treasury Stock
Property Plant Equipment
Current Deferred Revenue
Inventory
Net Tangible Assets
Total Permanent Equity
Noncontrolling Interest In Consolidated Entity
Retained Earnings Total Equity
Short Term Investments
Long Term Debt Total
Capital Surpluse
Additional Paid In Capital
Deferred Long Term Liab
Non Current Liabilities Other
Deferred Long Term Asset Charges
Long Term Investments
Short Long Term Debt
Net Invested Capital
Net Working Capital
Capital Stock
Capital Lease Obligations
Depreciation And Amortization
Interest Expense
Total Revenue
Gross Profit
Other Operating Expenses
Operating Income
Ebit
Ebitda
Cost Of Revenue
Total Operating Expenses
Income Before Tax
Total Other Income Expense Net
Income Tax Expense
Selling General Administrative
Net Income Applicable To Common Shares
Net Income From Continuing Ops
Non Operating Income Net Other
Minority Interest
Tax Provision
Interest Income
Non Recurring
Net Interest Income
Discontinued Operations
Reconciled Depreciation
Extraordinary Items
Probability Of Bankruptcy
Understanding current and past Ensign Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Ensign's financial statements are interrelated, with each one affecting the others. For example, an increase in Ensign's assets may result in an increase in income on the income statement.
Ensign competes with Enhabit, Pennant, InnovAge Holding, National HealthCare, and Select Medical. The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses. The company was incorporated in 1999 and is based in San Juan Capistrano, California. Ensign operates under Medical Care Facilities classification in the United States and is traded on NASDAQ Exchange. It employs 25900 people.
Comparative valuation techniques use various fundamental indicators to help in determining Ensign's current stock value. Our valuation model uses many indicators to compare Ensign value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ensign competition to find correlations between indicators driving Ensign's intrinsic value. More Info.
The Ensign Group is rated # 3 in return on equity category among its peers. It is rated below average in return on asset category among its peers reporting about 0.28 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for The Ensign Group is roughly 3.53 . At this time, Ensign's Return On Equity is most likely to slightly decrease in the upcoming years. Comparative valuation analysis is a catch-all technique that is used if you cannot value Ensign by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Ensign Group Systematic Risk
Ensign's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Ensign volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Ensign Group correlated with the market. If Beta is less than 0 Ensign generally moves in the opposite direction as compared to the market. If Ensign Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Ensign Group is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Ensign is generally in the same direction as the market. If Beta > 1 Ensign moves generally in the same direction as, but more than the movement of the benchmark.
Ensign Thematic Clasifications
The Ensign Group is part of several thematic ideas from Obamacare to Healthcare. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic Ideas
Today, most investors in Ensign Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Ensign's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Ensign growth as a starting point in their analysis.
Along with financial statement analysis, the daily predictive indicators of Ensign help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of The Ensign Group. We use our internally-developed statistical techniques to arrive at the intrinsic value of The Ensign Group based on widely used predictive technical indicators. In general, we focus on analyzing Ensign Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Ensign's daily price indicators and compare them against related drivers.
When running Ensign's price analysis, check to measure Ensign's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ensign is operating at the current time. Most of Ensign's value examination focuses on studying past and present price action to predict the probability of Ensign's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ensign's price. Additionally, you may evaluate how the addition of Ensign to your portfolios can decrease your overall portfolio volatility.